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Most members of the large family of rhodopsin-like G-protein-coupled receptors possess an evolutionarily conserved Asp-Arg-Tyr (DRY)
motif in the C-terminal region of the third transmembrane domain. Mutations of residues within this motif usually abolish receptor function and,
when they occur naturally, can even cause human diseases. By analyzing over 100 mammalian orthologs of the chemoattractant receptor GPR33
we identified several polymorphic and fixed sequence variations within the DRY motif. Unexpectedly, the naturally occurring mutation of Arg3.50
to His in mouse GPR33 showed no difference from the wild-type receptor in several functional tests. Sequence analysis of GPR33 from Asian
house mice revealed the polymorphic existence of Arg3.50 and His3.50 alleles in wild-trapped populations, further supporting the functional
equivalence of both allelic variants. In contrast, the Arg3.50 to Gly mutation found in hamster GPR33 inactivates the receptor and may have
contributed to pseudogenization of this gene in this species. Functional data with GPR33 variants indicate different receptor- and context-specific
consequences of DRY mutations. Our study also reveals GPR33 as a new example illustrating missense mutations as a first step in the
pseudogenization process.
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between G-protein-coupled receptors (GPCR) and the remark-
able structural variety of their natural agonists, all GPCR share a
common molecular architecture consisting of seven transmem-
brane domains (TMD) connected by three extra- and three
intracellular loops (ICL). This global architecture is maintained,
in part, by amino acid motifs and highly conserved residues,
which are also used to categorize GPCR into several families.
Most members of the rhodopsin-like family of GPCR possess
within their TMD core a number of highly conserved motifs,Abbreviations: AVPR2, V2 vasopressin receptor; DMEM, Dulbecco's
modified Eagle's medium; GPCR, G-protein-coupled receptor; HA, hemagglu-
tinin; ICL, intracellular loop; Myr, million years; mGPR33, murine GPR33;
TMD, transmembrane domain.
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doi:10.1016/j.ygeno.2006.02.009such as a DRY motif (Asp3.49-Arg3.50-Tyr3.51; numbering refers
to the absolute-position-independent nomenclature for GPCR
introduced by Ballesteros and Weinstein [1]) at the TMD3/ICL2
transition and an N/DPXXY motif in TMD7. The DRY motif
plays an essential role in GPCR function (reviewed in [2]). The
crystal structure of rhodopsin and numerous experimental data
suggest that the residues of the DRY motif form a cage-like
structure through hydrogen bonding with residues in close
proximity to the DRY motif and with surrounding residues of
TMD [3,4].
Previous studies examined the contribution of individual
DRY motif residues to receptor function and found two critical
residues. First, mutation of Asp3.49 results in constitutive
activity of many receptors [5,6]. Second, the almost fully
conserved Arg3.50 in the DRY motif is considered a key residue
in GPCR signal transduction since replacement of Arg3.50 with
different amino acids virtually abolishes G-protein coupling of
many GPCR [7–10]. Consequently, several naturally occurring
mutations have been found at position Arg3.50 in patients
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distinct GPCR [11]. Further, missense mutations in the DRY
motif have been implicated in pseudogenization of GPCR
[12,13]. The fact that a single missense mutation in a GPCR can
functionally inactivate the receptor is of importance since most
pseudogene annotations, e.g., in the odorant GPCR field, are
classically based on obvious signatures like premature trunca-
tion or frame disruptions to ascertain their nonfunctionality
[14,15].
We recently examined the evolution of the orphan chemoat-
tractant receptor GPR33 [16]. This chemoattractant GPCR
appeared with the first mammals but became inactivated during
the past 1 million years (Myr) in humans, as well as in several
great ape and rodent species. The coincidental inactivation and
fixation of GPR33 in several species of distantly related
mammalian orders suggest a selective pressure on this
chemoattractant receptor gene [16]. GPR33 appears to be intact
in most mammals; however, for a rhodopsin-like GPCR, this
receptor displays an unusually high diversification at the amino
acid level, including the otherwise highly conserved DRY
motif.
Here, we analyzed the functional consequences of sequence
variations within the GPR33 DRY motif during evolution.
Despite an absolute conservation of Asp3.49 in over 100 cloned
GPR33 orthologs, this residue was substituted to Ala or Gly in
all investigated species of the genus Mus and the subfamily
Gerbillinae. The functional consequence of this change is an
increase in basal receptor activity. By screening several Mus
musculus subspecies we identified an allelic variant (Arg3.50His)
in wild-captured Asian house mouse (M. musculus castaneus)
individuals. This amino acid change is known to inactivate
many GPCR [12,17–20]; however, it does not influence
GPR33 function. Our evolutionary, experimental, and in vivo
findings indicate that mutations in the DRY motif do not
necessarily inactivate GPCR function. Therefore, the func-
tional relevance of residues in highly conserved motifs, like
the DRY motif, cannot be generalized to all rhodopsin-like
GPCR.
Results
The GRP33 DRY motif displays an unusually high sequence
variability in mammals
Sequences analysis of more than 100 mammalian GPR33
orthologs revealed a high amino acid sequence variability in
comparison to other mammalian GPCR ortholog sets. This
variability is also observed in motifs that are highly conserved
among most rhodopsin-like GPCR. In previous work we
showed that after the rat–mouse evolutionary split, Asp3.49 in
the DRY motif was substituted by Ala thereby increasing basal
activity of murine GPR33 [16]. The variability of the conserved
DRY motif became more apparent when the number of
individuals examined was increased and further mammalian
species were included in the analysis (Fig. 1). First, in all gerbil
GPR33 orthologs investigated, Asp3.49 is substituted by Gly
(Fig. 1B). Second, Arg3.50His is fixed in several gerbil speciesand polymorphic in both the Asian house mouse (M. m.
castaneus) and Geoffroy's marmoset (Callithrix geoffroyi).
Further, Arg3.50 is substituted by Gly in Syrian hamster
(Microcricetus aureus). Because Asp3.49 and Arg3.50 mutations
have been implicated in diverse GPCR dysfunctions, we set out
to evaluate the functional relevance of these naturally occurring
DRY variants. This analysis may be of importance since
missense mutations are very rarely linked to pseudogenization
events.
Functional relevance of Asp3.49 variants in mammalian GPR33
orthologs
Two natural DRY motif variants, Ala3.49 and Gly3.49 (see
above), were found at position 3.49. We recently showed that
basal signal transduction abilities of orphan GPCR can be
studied even without agonist stimulation when the receptor and
appropriate chimeric G protein are coexpressed [21]. To
examine signal transduction abilities of the Gi-coupled
GPR33 and its mutant variants we coexpressed them with
GαΔ6qi4myr [22] in COS-7 cells and determined basal receptor
activity in inositol phosphate (IP) assays. For control purposes
the ADP receptor P2Y12, which displays a high basal activity in
this system [21], was included in all assays (Fig. 2).
In all species of the subfamily Murinae investigated, Asp3.49
is substituted by Ala and an increased (2.9-fold over basal) basal
activity of the mGPR33 was observed (Fig. 2) [16]. Reversal of
Ala3.49 (ARY) to Asp3.49 (DRY) abolishes this elevated basal
activity but has no influence on cell surface expression as
determined by indirect cellular ELISA. We next assessed the
Gly3.49 mutant (GRY) found in all gerbil orthologs (see Fig. 1).
Compared to wild-type mGPR33 (ARY), Ala3.49Gly showed an
increased basal activity (1.7-fold elevation above basal)
accompanied by a reduced cell surface expression (∼76% of
mGPR33). These data indicate that, in the subfamily Gerbillinae
and in the genus Mus, the increase in basal GPR33 activity
occurred by independent mutation of the DRY motif.
Previous studies with other GPCR showed that several
amino acid residues (e.g., Thr, Gln) at position 3.49 lead to
constitutive receptor activity [23]. To test whether constitutive
activation of GPR33 is specific to Ala and Gly substitutions, we
generated Thr3.49 (TRY) and Gln3.49 (QRY) and analyzed their
activity as described above. As shown in Fig. 2, both mutants
displayed no significant increase in basal IP formation
compared to the control or DRY variant. Determination of cell
surface expression, an essential prerequisite for proper signal
transduction, revealed a loss of plasma membrane expression
for both mutant GPR33. This finding indicates that GPR33
activation by mutation of the DRY motif depends on the amino
acid substitution.
The Arg3.50His mutation occurs naturally in GPR33 of wild M.
m. castaneus
Arg3.50 within the DRY motif is one of the most conserved
residues in rhodopsin-like GPCR. However, our sequence
analysis revealed several mutations of Arg3.50, mainly to His
Fig. 1. Structural variability of the DRY motif in mammalian GPR33 orthologs. (A) The DRY motif is located at the TMD3/ICL2 transition of rhodopsin-like GPCR.
(B) The amino acid sequence of the TMD3/ICL2 transition of various mammalian GPR33 orthologs contains a highly conserved DRY motif (gray highlight).
Variations in the DRY motif are boxed. The numbers in parentheses indicate the numbers of species of that order also containing a DRY motif in GPR33 (for sequence
details see Accession Nos. AY490569–AY490743, AY493989–AY494004, AY502103, AY502104, AY528865). The alignment on the right shows the DRY motif of
only rodent species. ICL, intracellular loop; TMD, transmembrane domain.
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Geoffroy's marmoset. Because such Arg3.50His mutations are
known to inactivate GPCR in vitro and in vivo [12,17–20], we
speculated that the polymorphic occurrence of Arg3.50His may
reflect an ongoing pseudogenization of GPR33. We identified
the Arg3.50His allele in an inbred laboratory strain of M. m.
castaneus (CIM strain according to the nomenclature of the
Laboratoire Génome Populations Interactions Adaptation at the
Universite Montpellier, France), which may reflect either
natural polymorphisms present in the wild population or a
new polymorphism that has been introduced during captivity.To distinguish between these possibilities, we sequenced the
coding region from 88 wildM. m. castaneus trapped in Taiwan.
Three allelic variants of GPR33 were found in these rural Asian
house mice (Fig. 3A). Allele 1 and allele 2 are almost identical
to those ofM. m. domesticus (10 individuals tested), but allele 3
(Arg3.50His allele) contains five substitutions, three of which are
nonsynonymous. Analysis of the geographic distribution of
allele 3 showed its abundant presence in all regions of Taiwan
(Fig. 3B).
The Arg3.50His mutation in the Asian house mouse took
place after divergence from other M. musculus subspecies. To
Fig. 2. Functional characterization of mutations at relative position 3.49 in
mouse GPR33. In most mammalian GPR33 orthologs the relative position 3.49
is an Asp. However, in Mus and Gerbillinae Asp3.49 is substituted by Ala and
Gly, respectively. Replacement of the four to five C-terminal amino acids of Gαq
with the corresponding Gαi residues (referred to as GαΔ6qi4myr) confers the
ability to stimulate the PLC-β pathway onto Gi-coupled receptors [22]. To test
for basal receptor activity, GPR33 receptor constructs were coexpressed with the
chimeric GαΔ6qi4myr protein in COS-7 cells and inositol phosphate (IP) assays
were performed as described (Materials and methods). As controls, plasmids
encoding GFP and the human P2Y12 were cotransfected with GαΔ6qi4myr. Basal
IP formation is expressed as fold over basal levels of GFP-transfected cells
(544 ± 15 cpm/well). Data are presented as means ± SD of two independent
experiments, each carried out in triplicate. Cell surface expression levels of the
GPR33 mutant receptors were measured by indirect cellular ELISA (Materials
and methods). Specific optical density (OD) readings (OD value of HA-tagged
GPR33 construct minus OD value of GFP-transfected cells) are given as a
percentage of wild-type HA-tagged GPR33. The nonspecific OD value (GFP)
was 0.089 ± 0.031, and the OD value of the wild-type HA-tagged GPR33 was
0.485 ± 0.116. ELISA data are given as means ± SD of eight independent
experiments, each carried out in quadruplicate.
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and 3′ noncoding genomic regions flanking the GPR33 coding
region of M. m. castaneus (allele 1 and allele 3), M. m.
domesticus (one allele), Rattus norvegicus (two alleles) [16],
and Rattus rattus. Comparison of ∼2.6 kb of homologous
genomic sequence revealed an average of 140.4 ± 0.5 muta-
tions/1000 bp between Mus alleles and the corresponding
Rattus sequences (see Supplemental Table S1). The Asian
house mouse allele 1 and allele 3 differ from each other by 6.6
substitutions/1000 bp. Thus, by comparison with the divergence
ofMus and Rattus (about 12 to16–23 Myr ago) [24,25] and that
of R. rattus and R. norvegicus (about 5.5 Myr ago) [26], we
estimate that the divergence of the M. m. castaneus His3.50-
containing allele 3 from both the Arg3.50-containing alleles of
M. m. domesticus andM. m. castaneus (allele 1) occurred about
1.07 ± 0.37 Myr ago (range min 0.64 to max 1.56 Myr,
depending on the time point for Mus/Rattus divergence
[24,25]).
Arg to His mutation does not influence receptor function in
vitro
Previous studies with the V2 vasopressin receptor (AVPR2),
the angiotensin type 1 receptor, and β2 adrenergic receptorshowed that the Arg3.50His mutation leads to a loss of cell
surface expression due to constitutive receptor internalization
[20,27]. To analyze the functional consequence of Arg3.50His in
mGPR33 we expressed wild-type (ARY) and mutant (AHY)
receptors in COS-7 cells, performed second messenger assays,
and measured cell surface expression by ELISA. Interestingly,
both wild-type and Arg3.50His receptors showed similar cell
surface expression levels and basal activities (Table 1).
Similarly, cell surface expression measured in transiently
transfected CHO cells (transfectable cell system with lower
receptor expression levels when pcDps vector is used) was
indistinguishable between the mutant (Arg3.50His) and the wild-
type mGPR33 (data not shown).
In the M. m. castaneus GPR33 ortholog, the Arg3.50His
mutation cosegregates with other synonymous and nonsynon-
ymous substitutions (Fig. 3A). To exclude the possibility that
Arg3.50His inactivates GPR33 only in the context of the M. m.
castaneus allele 3 (see Fig. 3A) we cloned and expressed an
epitope-tagged version of allele 3. Again, no differences in
signaling abilities or cell surface expression were found
compared with the wild-type mGPR33 (allele 1 in Fig. 3A,
see Table 1).
As mentioned above, previous studies showed that in several
GPCR the Arg3.50His mutation triggers constitutive β-arrestin-
mediated desensitization. Even in the absence of agonist the
sequestered receptors were found in β-arrestin-associated
intracellular vesicles [27]. We examined GPR33-Arg3.50His
localization with respect to β-arrestin-associated vesicles by
confocal microscopy of transfected human embryonic kidney
(HEK) cells. For control purposes AVPR2 was cotransfected
with β-arrestin–GFP and stimulated with 10 nM vasopressin
(AVP). As shown in Fig. 4, AVP stimulation leads to β-arrestin-
mediated desensitization of AVPR2 by formation of internalized
vesicles with colocalized AVPR2 and β-arrestin. The wild-type
mGPR33 (ARY variant in Fig. 4) showed membrane localiza-
tion while β-arrestin–GFP remained cytosolic. The same
pattern of localization was also seen with the Arg3.50His mutant
(AHY in Fig. 4), indicating the lack of constitutive internali-
zation of the mutant receptor.
The Arg3.50His mutation-mediated constitutive receptor
internalization was originally found in GPCR containing a
classical DRY motif [20,27]. In the wild-type murine
GPR33, Asp3.49 of the DRY motif is substituted by Ala
(ARY motif) [16]. To test whether the unchanged cell
surface expression of GPR33-Arg3.50His is caused by this
difference in the DRY motif we analyzed Arg3.50His in the
DRY background (GPR33-DHY mutant). The DHY variant
naturally occurs in marmoset (C. geoffroyi, see Fig. 1B). As
shown in Table 1, cell surface expression of GPR33-DHY is
slightly reduced compared with ARY and AHY. The
decrease in cell surface expression was not due to a
reduction in total cellular expression of the mutant receptor
as determined by a sandwich ELISA (Table 1). In the Syrian
hamster GPR33 ortholog Arg3.50 is mutated to Gly in the
DRY context (DGY, see Fig. 1B). In contrast to mGPR33-
DHY, Arg3.50 substitution by Gly results in an almost
complete loss of cell surface expression (Table 1).
Fig. 3. GPR33 alleles in Asian house mouse and their frequency and geographic distribution in Taiwan. (A) Sequencing of the coding region of GPR33 from Asian
house mouse (M. m. castaneus) revealed three alleles. Allele 1 is identical to that ofM. m. domesticus, whereas allele 2 and allele 3 contain differences at the indicated
codon positions. (B) To determine allele frequencies (given in %) 88 wild-captured Asian house mice from six different regions in Taiwan [31] were analyzed by
sequencing.
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expression of mGPR33-DHY is due to β-arrestin-mediated
desensitization, immunofluorescence studies (see above) were
performed. As expected from ELISA data, both GPR33 variants,
GPR33-DRY and GPR33-DHY, were expressed at the plasma
membrane. Additionally, an increase in intracellular reticular
fluorescence was found for GPR33-DHY (Supplemental Fig.
S1). However, no differences inβ-arrestin distribution and noβ-
arrestin-containing vacuoles were found in GPR33-DHY,
indicating that Arg3.50His mutation in the DRY context slightly
interferes with proper cell surface expression.
To test whether the lack of an arrestin-mediated internaliza-
tion is restricted to Arg3.50 mutants of GPR33, the ADP receptor
P2Y12 was mutated in its DRY motif to DHY. Similar to the
finding with GPR33-DHY, Arg3.50His mutation of P2Y12
partially reduces receptor cell surface expression but no β-
arrestin-mediated internalization was found (Table 1, Supple-
mentary Fig. S1).
To evaluate further the individual influence of amino acids at
position 3.50 on basal receptor activity and cell surface
expression, Arg3.50 was substituted by other amino acids in
mGPR33. As shown in Table 1, basic residues (Arg, His, Lys)
are well tolerated with respect to plasma membrane expression
and basal activity of mouse GPR33. However, all other
mutations lead to loss of basal activity (Gln, Trp, Thr) and/or
cell surface expression (Ser, Leu, Glu, Gly). The latter
phenotype was probably due to intracellular retention because
total cellular expression remained unchanged in most mutant
GPR33 (Table 1).Discussion
Although mammalian genomes have maintained a relatively
constant number of GPCR throughout evolution, several of
these receptor genes have become inactivated in some species.
One such example is the chemoattractant receptor GPR33,
which became inactivated in humans, as well as in several great
ape and rodent species in fairly recent time [16]. Pseudogeniza-
tion of a gene can often be detected when hallmark disruptions
to the reading frame, such as deletions, insertions, or stop
codons, are present. However, about 65% of all inactivating
mutations found naturally in GPCR are missense mutations,
which can be identified only by functional testing [11]. More
than 80% of such missense mutations hit highly conserved
residues. Therefore, it is likely that GPCR pseudogenization,
especially if very recent, can escape detection by undirected
sequence analysis.
By examining the DRY motif of over 100 mammalian
GPR33 orthologs we identified different sequence variations
which could alter receptor function. Asp3.49 in the DRY motif
was found to be substituted by Ala (Mus) and Gly (Gerbillinae),
both of which mutants were compatible with functional receptor
trafficking and signal transduction. Moreover, both mutations
increased basal receptor activity. In the crystal structure of
rhodopsin [3], the acidic residue at position 3.49 forms a salt
bridge with Arg3.50 of the DRY motif. Numerous reports show
that mutation of the acidic residue in the DRY motif disrupts
this ionic interaction and results in increased basal activity of
many receptors [28]. But there are several functional rhodopsin-
Table 1
Functional characterization of Arg3.50 mutations introduced into mouse GPR33
Mutation Basal IP
formation
(fold over
basal)
Cell surface
expression
(% of ARY)
Total cellular
expression
(% of ARY)
GFP 1 0a 0b
ARY (wild type) 3.2 ± 0.2 100c 100d
AHY 3.2 ± 0.1 138 ± 21 104 ± 6
AHY (M. m. castaneus.) 3.2 ± 0.2 87 ± 18 116 ± 13
DHY 1.0 ± 0.1 69 ± 10 ⁎ 106 ± 7
DRY 1.1 ± 0.1 150 ± 32 93 ± 5
DGY 1.1 ± 0.1 38 ± 16 ⁎ 103 ± 30
P2Y12 (DRY) 5.7 ± 0.1 291 ± 46 97 ± 13
P2Y12-DHY 2.2 ± 0.1 219 ± 38 110 ± 4
AKY 3.2 ± 0.2 102 ± 22 110 ± 8
AQY 1.4 ± 0.3 165 ± 38 112 ± 7
AWY 1.1 ± 0.1 120 ± 35 129 ± 19
ATY 1.0 ± 0.1 99 ± 38 120 ± 4
ASY 1.0 ± 0.1 33 ± 20 ⁎ 125 ± 16
AAY 1.0 ± 0.2 29 ± 13 ⁎ 114 ± 17
ALY 1.1 ± 0.1 14 ± 10 ⁎ 123 ± 12
AEY 1.0 ± 0.2 22 ± 10 ⁎ 104 ± 12
AGY 1.1 ± 0.1 25 ± 15 ⁎ 49 ± 24
Wild-type and the mutant mouse GPR33 and human P2Y12 constructs were
coexpressed with the chimeric GαΔ6qi4myr protein in COS-7 cells and IP assays
were performed as described (Materials and methods). As a negative control a
plasmid encoding GFP was cotransfected with GαΔ6qi4myr. Basal IP formation is
presented as fold over GFP-transfected cells (544 ± 15 cpm/well). Data are
presented as means ± SD of two to four independent experiments, each carried
out in triplicate. Cell surface and total cellular level expression of the wild-type
and mutant receptors were measured by a cell surface ELISA and sandwich
ELISA. Specific optical density (OD) readings (OD value of HA-tagged
construct minus OD value of GFP-transfected cells) are given as a percentage of
wild-type HA-tagged GPR33. The nonspecific OD value (GFP) was
0.089 ± 0.031 (aset as 0%) and 0.175 ± 0.033 (bset as 0%), and the OD value
of the wild-type HA-tagged GPR33 was 0.485 ± 0.116 (cset as 100%) and
1.144 ± 0.116 (dset as 100%). ELISA data are given as means ± SD of four to
seven (cell surface ELISA) and two or three (sandwich ELISA) independent
experiments, each carried out in quadruplicate.
⁎ Significant reduction in cell surface expression (P < 0.005).
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naturally substituted by Ala (relaxin receptors) or Gly (free fatty
acid receptor 1, GPR40). Therefore, our functional analysis of
GPR33 orthologs suggests that the Asp3.49 substitutions
identified in mouse and gerbil species are compatible with
proper receptor function. It should be noted that GPR33 is
pseudogenized in all gerbil species because of truncating or
frame-disrupting mutations that obviously occurred after
speciation. Since Asp3.49Gly is found in all gerbil species,
this substitution must have occurred before receptor
inactivation.
In contrast to position 3.49, naturally occurring substitutions
of Arg3.50 in GPCR without obvious functional changes are
very rare but include LGR8, CCBP2, and GPR1. Most
mutations of Arg3.50 in rhodopsin-like GPCR, including
mutations to His, lead to receptor inactivation (see references
above). Although there is only one experimentally proven
example of GPCR pseudogenization by a missense mutation
[12], we speculated that the Arg3.50His mutation found to be
polymorphic in the Asian house mouse may inactivate GPR33.However, all tests (cell surface expression, IP assay, β-arrestin
recruitment) revealed equivalent function of Arg3.50His com-
pared with wild-type GPR33. In respect to cell surface
expression, minor context-specific differences were observed
(AHY versus DHY, see Table 1). Systematic substitution of
Arg3.50 in mGPR33 showed that not only His but all basic
amino acid residues are functionally tolerated in this position.
We cannot exclude more distinct functional differences between
the Arg3.50 and the His3.50 variants, as shown for the agonist-
induced internalization kinetics of the V1a vasopressin receptor
[29]. However, the allele frequency, the presence of several
allelic variants at other sites in complete linkage disequilibrium
with His3.50, and the allele age estimates all suggest a long
natural coexistence of both alleles. Further, initial characteriza-
tion of mouse strains homozygous for either Arg3.50 or His3.50
revealed no obvious differences in mating, behavior, blood cell
counts, and morphological characteristics (Römpler and
Schöneberg, unpublished data).
Until the agonist for GPR33 is identified the functional
relevance of Gln, Trp, and Thr substitution at position 3.50 will
remain an open question because receptors bearing these
mutations are still expressed at the cell surface and only a loss of
basal receptor activity is observed. The loss of basal activity
does not automatically implicate a loss of agonist-induced
receptor function. However, significant alteration of receptor
function (loss of cell surface expression and basal activity) was
observed by mutating Arg3.50 to Ser, Leu, Glu, and Gly. The
majority (more than 80%) of disease-causing inactivating
missense mutations found in GPCR lead to improperly folded
proteins that are retained intracellularly by the endoplasmic
reticulum quality control system [30] and, therefore, escape
agonist stimulation and signal transduction through the plasma
membrane. It is therefore very likely that the Arg3.50Gly
mutation found in the Syrian hamster GPR33 ortholog
inactivates the receptor. However, the hamster ortholog displays
a frameshifting mutation; thus it remains unclear whether this
deletion or the Arg3.50Gly mutation was responsible for
pseudogenization.
Conclusion
Our analysis of more than 100 mammalian orthologs of the
chemoattractant receptor GPR33 provided an excellent evolu-
tionary history of a GPCR that underwent a variety of functional
fates. First, focusing on the highly conserved DRY motif, we
found that mutations increased the basal activity of this receptor
in Mus and Gerbillinae species before the receptor became
pseudogenized in the Gerbillinae subfamily. Second, because of
the DRY motif diversity observed in vivo, the functional
relevance of residues within this motif appears to be receptor
and context-specific. In contrast to many other GPCR, the
conserved Arg3.50 of mGPR33 can be substituted by other basic
amino acids without obvious loss of receptor function as shown
in in vitro tests and as implicated by the long natural coexistence
of Arg3.50 and His3.50 variants. On the other hand there is
evidence that other Arg3.50 mutations in GPR33 can be
inactivating, as illustrated by Arg3.50Gly in hamster. The latter
Fig. 4. Lack of β-arrestin-mediated desensitization of the AHY mGPR33 variant. HEK cells were cotransfected with β-arrestin–GFP and HA-tagged versions of the
V2 vasopressin receptor (AVPR2), wild-type mGPR33 (GPR33-ARY), or the mGPR33-Arg3.50His (GPR33-AHY) variant. Cells were fixed and permeabilized and
HA-tagged GPCR were detected with an anti-HA monoclonal antibody and a TRITC-labeled anti-mouse antibody. For control purposes, AVPR2-transfected cells
were incubated 10 nM AVP for 20 min at 37°C prior to fixation. Specific fluorescence of HA-tagged GPCR (red) and GFP (green) and the overlay of both
fluorescences plus the differential interference contrast image are shown. The inset (overlay AVPR2 + AVP) depicts internalization vesicles at a higher magnification.
Scale bars, 10 μm. The pictures shown are representative of at least four additional independent experiments. The cotransfection efficiency (obvious receptor and
arrestin fluorescence related to transfected cells) was 51 ± 8% (20 randomly chosen transfected cells were counted per independent experiment). In the case of AVPR2
90 ± 6% of all cotransfected cells displayed double-fluorescent internalization vacuoles upon AVP stimulation.
730 H. Römpler et al. / Genomics 87 (2006) 724–732finding further supports the idea that recent pseudogenization
events due to inactivating missense mutations in GPCR, and
likely in other proteins as well, can escape simple bioinfor-
matics inspection of genes.
Materials and methods
GPR33 ortholog identification and site-directed mutagenesis
To analyze the sequence of GPR33 orthologs, genomic DNA samples were
prepared from tissue or peripheral mononuclear blood cells of various
mammalian species (sources are given in Supplemental Table S2). Tissue
samples were digested in lysis buffer (50 mM Tris/HCl, pH 7.5, 100 mM EDTA,
100 mM NaCl, 1% SDS, 0.5 mg/ml proteinase K) and incubated at 55°C for
18 h. DNA was purified by phenol/chloroform extraction and ethanol
precipitation. Degenerate primer pairs (Supplemental Table S3) were applied
to amplify GPR33-specific sequences. PCRs were performed with Taq
polymerase under variable annealing and elongation conditions. Conditions of
a standard PCR were as follows: Genomic DNA (100 ng) was used in PCRs
(50 μl) with primers (10 pmol each), standard buffer (Perkin–Elmer), dNTP
(200 μM), and Taq polymerase (1 U; Perkin–Elmer). The reactions were
initiated with a denaturation at 94°C for 3 min, followed by 35 cycles of
denaturation at 94°C for 45 s, annealing at 60°C for 45 s, and elongation at 72°C
for 2 min. A final extension step was performed at 72°C for 10 min. Specific
PCR products were sequenced directly and/or subcloned into the pCR2.1-TOPO
vector (Invitrogen, La Jolla, CA, USA) for sequencing. In the case of
heterozygosity allelic separation was performed by subcloning and subsequent
sequencing. Sequencing reactions were performed on PCR products with a dye-
terminator cycle sequencing kit (Applied Biosystems) on an ABI 3700automated sequencer (Applied Biosystems). Based on considerable sequence
similarities of the 5′ and 3′ untranslated regions of GPR33 genes, primers were
designed (Supplemental Table S3) that allowed for the identification of
sequences encoding the N and C termini of mammalian GPR33 orthologs.
To determine the frequency of allelic variants in M. m. castaneus we
sequenced the GPR33 coding region of 88 wild-caught animals from
Taiwan [31]. Here, PCR fragments were amplified with genomic DNA
samples and primers (Supplemental Table S3). PCR products were separated
in a 1% agarose gel, purified by using a gel extraction kit (Qiagen), and
sequenced.
The full-length mGPR33 and the human P2Y12 were inserted into the
mammalian expression vector pcDps and epitope-tagged with an N-terminal HA
epitope and a C-terminal FLAG epitope by a PCR-based overlapping fragment
mutagenesis approach [16,21]. Mutations were introduced into the double-
tagged versions of the murine GPR33 and human P2Y12 using a PCR-based site-
directed mutagenesis and restriction fragment replacement strategy. The identity
of the various constructs and the correctness of all PCR-derived sequences were
confirmed by restriction analysis and sequencing.
Cell culture and functional assays
COS-7 cells and HEK 293 cells were grown in Dulbecco's modified Eagle's
medium (DMEM) supplemented with 10% fetal bovine serum, 100 U/ml
penicillin, and 100 μg/ml streptomycin at 37°C in a humidified 7% CO2
incubator. LipofectAMINE (Invitrogen) was used for transient transfection of
COS-7 cells. Subsequently cells were split into 12-well plates (1.5 × 105 cells/
well) and transfected with a total amount of 1 μg of plasmid DNA/well. To
measure IP formation, transfected COS-7 cells were incubated with 2 μCi/ml
myo-[3H]inositol (18.6 Ci/mmol; Perkin-Elmer) for 18 h. Thereafter, cells were
washed once with serum-free DMEM containing 10 mM LiCl followed by
731H. Römpler et al. / Genomics 87 (2006) 724–732incubation for 1 h at 37°C. Intracellular IP levels were determined by anion-
exchange chromatography as described [32].
ELISA and immunofluorescence studies
To estimate cell surface expression of receptors carrying an N-terminal HA
tag, we used an indirect cellular ELISA [33]. To assess further the amounts of
full-length HA/FLAG-double tagged GPR33 and P2Y12 constructs and to
demonstrate that the reduction of cell surface expression levels is not due to a
decrease in receptor expression in general, a previously developed “sandwich
ELISA” was used [17]. In brief, transfected cells were harvested from 6-cm
dishes, and membrane preparations were solubilized in lysis buffer (10 mM
Tris–HCl, pH 7.4, 150 mMNaCl, 1 mMDTT, 1 mM EDTA, 1% desoxycholate,
1% Nonidet NP-40, 0.2 mM PMSF, 10 μg/ml aprotinin) overnight. Microtiter
plates (Maxi Sorp, Nunc Immuno plates; Nunc) were coated with a monoclonal
antibody directed against the C-terminal FLAG tag (10 μg/ml in 0.05 M borate
buffer, M2 antibody; Sigma). After incubation with the solubilized membranes,
bound full-length receptor proteins were detected with the combination of a
biotin-labeled anti-HA monoclonal antibody (12CA5; Roche Molecular
Biochemicals) and a peroxidase-labeled streptavidin conjugate (Sigma) and a
color reaction [17].
Immunofluorescence studies were carried out to examine the subcellular
distribution of the various receptor constructs and bovine β-arrestin-2-GFP
(generous gift of Professor M. Lohse, Würzburg). HEK cells were transferred
into six-well plates containing sterilized glass coverslips and transfected. For
immunofluorescence staining cells were fixed 48 h after transfection,
permeabilized with 0.1% Triton X-100 in PBS (PBS-T), and probed with a
monoclonal anti-HA antibody (Roche; 10 μg 12CA5 in PBS-T). The primary
mouse antibody was detected using an anti-mouse-IgG TRITC-labeled
secondary antibody (Sigma). Fluorescence images were obtained with a
confocal laser-scanning microscope (LSM 510; Carl Zeiss Jena, Jena,
Germany).
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